136941-68-9

Basic information

• Product Name: 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-(1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)propyl methyl ester
• CAS NO: 136941-68-9
• Molecular Formula: C26H25N3O9S
• Molecular Weight: 555.565
• Mol File: 136941-68-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-(1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)propyl methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-(1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)propyl methyl ester(136941-68-9)
• EPA Substance Registry System: 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-(1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)propyl methyl ester(136941-68-9)

Safety Data

• Hazardous Substances Data: 136941-68-9(Hazardous Substances Data)

Upstream product

• 99-61-6 3-nitro-benzaldehyde 
• 14205-39-1 methyl (E)-3-aminocrotonate 
• 147701-47-1 3-Oxo-butyric acid 3-(1,1,3-trioxo-1,3-dihydro-1λ⁶-benzo[d]isothiazol-2-yl)-propyl ester 
• 14205-39-1 methyl 3-aminocrotonate 

Relevant articles and documents

1,4-dihydropyridine derivatives, a process for their preparation and their use for influencing the blood flow

The invention relates to new 1,4-dihydropyridine derivatives of the general formula I STR1 in which R1, R2, R3 and n have the meaning stated in the patent claims. The compounds of the invention have a vasodilatory effect and are therefore suitable for the treatment of hypertension. Some of the compounds have a vasoconstrictory effect and can therefore be used for the treatment of hypotension.

New 1,4-dihydropyridine derivatives, a process for their preparation and their use for influencing the blood flow

The invention relates to new 1,4-dihydropyridine derivatives of the general formula I in which R1, R2, R3 and n have the meaning stated in the patent claims. The compounds of the invention have a vasodilatory effect and are therefore suitable for the treatment of hypertension. Some of the compounds have a vasoconstrictory effect and can therefore be used for the treatment of hypotension.